HPGDS

Hematopoietic prostaglandin D synthase · O60760 · HPGDS on Sugi Atlas →

83,342 patent compounds predicted against HPGDS, 42,503 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL27589 SCHEMBL27589 1.00 20/20
SCHEMBL27787 SCHEMBL27787 1.00 20/20
SCHEMBL29363 SCHEMBL29363 1.00 20/20
SCHEMBL28492 SCHEMBL28492 0.81 20/20
SCHEMBL28039 SCHEMBL28039 1.00 19/20
SCHEMBL28315 SCHEMBL28315 1.00 19/20
SCHEMBL28514 SCHEMBL28514 1.00 19/20
SCHEMBL28944 SCHEMBL28944 1.00 19/20
SCHEMBL28314 SCHEMBL28314 0.73 19/20
SCHEMBL27313 SCHEMBL27313 1.00 18/20
SCHEMBL27841 SCHEMBL27841 1.00 18/20
SCHEMBL28180 SCHEMBL28180 1.00 18/20
SCHEMBL28360 SCHEMBL28360 1.00 18/20
SCHEMBL28504 SCHEMBL28504 0.92 18/20
SCHEMBL28861 SCHEMBL28861 0.71 18/20
SCHEMBL28221 SCHEMBL28221 0.69 18/20
SCHEMBL28222 SCHEMBL28222 1.00 17/20
SCHEMBL28755 SCHEMBL28755 1.00 17/20
Morpholine Morpholine (SCHEMBL28316) 0.59 17/20
SCHEMBL38259 SCHEMBL38259 1.00 16/20

Clinical trials — most relevant to HPGDS by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Type 2 Diabetes Mellitus and Atherosclerosis PHASE4UNKNOWN
Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes PHASE4UNKNOWN
A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus PHASE4COMPLETED
Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia PHASE4UNKNOWN
European Celecoxib Trial in Primary Breast Cancer PHASE3COMPLETED
Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes PHASE3UNKNOWN
Addition of Aspirin to Standard of Care in Oral Cancer PHASE2/PHASE3COMPLETED
Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial PHASE3UNKNOWN
Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite PHASE2/PHASE3WITHDRAWN
Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors PHASE1/PHASE2COMPLETED
Comparision Between Paracetamol and Ibuprofen in Closure of Patent Ductus Arteriosus PHASE2UNKNOWN
Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients PHASE2COMPLETED
Prostaglandin Inhibition for Emphysema PHASE2COMPLETED
Changes in Biomarkers Using Prostaglandin Inhibitors PHASE1/PHASE2COMPLETED
Trial of Zileuton CR in Children and Adults With Sickle Cell Disease PHASE1COMPLETED
Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B nanCOMPLETED
Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A nanACTIVE_NOT_RECRUITING
Study About Patients Using Copper Intrauterine Device nanCOMPLETED
Urinary PGE-MUM (PROSTAGLANDIN E-MAJOR URINARY METABOLITE) as Inflammatory Marker in Chronic Inflammatory Bowel Disease nanCOMPLETED
Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis nanCOMPLETED
EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish) nanUNKNOWN
Peri-implantitis and MMP-8 nanCOMPLETED
Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric Cancer nanUNKNOWN
The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis nanUNKNOWN
The Neuroprotective Effect of Dexmedetomidine Preserving Brain Functional Connectivity in Elderly Patients nanCOMPLETED
Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses nanCOMPLETED
Investigation of Lipoxin A4, Annexin A1 and Interleukin-1 Beta Levels in Individuals With Periodontitis. nanCOMPLETED
Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea nanRECRUITING
Impact of Vitamin D Supplementation on Hepcidin Levels and Transfusion Requirements in Surgical and Septic Patients nanUNKNOWN
Reactive Oxygen Species in the Pathogenesis of Diabetic Complications nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a HPGDS binder may also engage these)

ProteinNameSimilarity
O35543 0.996 O35543 →
Q9JHF7 0.996 Q9JHF7 →
P91252 0.993 P91252 →
P30114 0.990 P30114 →
Q09607 0.990 Q09607 →
Q08862 0.990 Q08862 →
Q21743 0.990 Q21743 →
P26624 0.989 P26624 →
P18426 0.989 P18426 →
P10299 0.988 P10299 →
P09792 0.988 P09792 →
Q21355 0.988 Q21355 →
O73888 0.987 O73888 →
P30113 0.987 P30113 →
Q08393 0.987 Q08393 →
O16116 0.987 O16116 →
O16115 0.987 O16115 →
Q9N4X8 0.986 Q9N4X8 →
Q54QV7 0.986 Q54QV7 →
P46419 0.986 P46419 →
P26697 0.985 P26697 →
Q7RTV2 0.985 Q7RTV2 →
P30115 0.985 P30115 →
Q08863 0.985 Q08863 →
GSTA1 Glutathione S-transferase A1 0.985 landscape →
P46427 0.985 P46427 →
P46426 0.985 P46426 →
Q5E9G0 0.985 Q5E9G0 →
P46088 0.984 P46088 →
Q08392 0.984 Q08392 →